Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126147451 | 12614745 | 1 | I | 20160726 | 20160729 | 20160802 | 20160802 | EXP | US-GLAXOSMITHKLINE-US2016110592 | GLAXOSMITHKLINE | 55.00 | YR | F | Y | 0.00000 | 20160802 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126147451 | 12614745 | 1 | PS | NICODERM CQ | NICOTINE | 1 | 21 MG, QD | 20165 | 21 | MG | TRANSDERMAL PATCH | QD | |||||||
| 126147451 | 12614745 | 2 | SS | NICODERM CQ | NICOTINE | 1 | 21 MG, UNK | 1514384 | 20165 | 21 | MG | TRANSDERMAL PATCH | QD | ||||||
| 126147451 | 12614745 | 3 | SS | NICODERM CQ | NICOTINE | 1 | 14 MG, QD | N | 1506518 | 20165 | 14 | MG | TRANSDERMAL PATCH | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126147451 | 12614745 | 1 | Product used for unknown indication |
| 126147451 | 12614745 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126147451 | 12614745 | Application site erythema | |
| 126147451 | 12614745 | Drug administered at inappropriate site | |
| 126147451 | 12614745 | Drug ineffective | |
| 126147451 | 12614745 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |